Twist Bioscience Corp (TWST) stock
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$112.00+6.96 (+6.63%)
Close on Nov 17, 2026Market cap $7.02BP/E –Yield –
Twist Bioscience market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Twist Bioscience's market cap was $7.68B on Nov 11, 2026, against $1.94B a year earlier. Over the last 5 years it ranged from $706.93M to $12.11B, with a median of $2.26B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.68B | +299.5% |
| 2025 | Dec 31, 2025 | $1.92B | -29.7% |
| 2024 | Dec 31, 2024 | $2.74B | +29.0% |
| 2023 | Dec 29, 2023 | $2.12B | +57.6% |
| 2022 | Dec 30, 2022 | $1.35B | -64.9% |
| 2021 | Dec 31, 2021 | $3.83B | -39.9% |
| 2020 | Dec 31, 2020 | $6.37B | +822.7% |
| 2019 | Dec 31, 2019 | $690.33M | +832.5% |
| 2018 | Dec 31, 2018 | $74.03M | – |
See a number that looks wrong?